Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #8182
Reference
MSAN(2024)34
Name
Imiquimod (Aldara®) 5% cream and podophyllotoxin (Warticon®) 0.5% solution and 0.15% cream
Categories
Scottish Government
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
Scotland
Health Boards
Pharmaceutical Services
Supplies
Drug Shortages
Description
Imiquimod (Aldara®) 5% cream will be out of stock from mid-June 2024 until late July 2024.
Podophyllotoxin (Warticon®) 0.5% solution is out of stock until mid-June 2024.
Podophyllotoxin (Warticon®) 0.15% cream is out of stock until mid-October 2024.
Imiquimod (Zyclara®) 3.75% cream remains available and can support a partial increase in demand.
Imiquimod (Bascellex®) 50 mg/g cream remains available and can support a partial increase in demand.
Fluorouracil (Efudix®) 5% cream remains available, however, cannot support any increase in demand.
Diclofenac (Solaraze®) 3% gel, fluorouracil with salicylic acid (Actikerall®) cutaneous solution and tirbanibulin (Klisyri®) ointment remain available and can support an increase in demand.
Camellia sinensis (Catephen®) 10% ointment remains available and can support a partial increase in demand.
Unlicensed supplies of imiquimod 5% cream may be sourced, lead times vary.
Contact Name
Contact Email
Contact Address
Created
2024-06-11 12:32:00
Click to go back to homepage